JP2022519239A5 - - Google Patents
Info
- Publication number
- JP2022519239A5 JP2022519239A5 JP2021544435A JP2021544435A JP2022519239A5 JP 2022519239 A5 JP2022519239 A5 JP 2022519239A5 JP 2021544435 A JP2021544435 A JP 2021544435A JP 2021544435 A JP2021544435 A JP 2021544435A JP 2022519239 A5 JP2022519239 A5 JP 2022519239A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- membered
- cycloalkyl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962798566P | 2019-01-30 | 2019-01-30 | |
| US62/798,566 | 2019-01-30 | ||
| PCT/US2020/015291 WO2020159904A1 (en) | 2019-01-30 | 2020-01-28 | Amide-disubstituted pyridine or pyridazine compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519239A JP2022519239A (ja) | 2022-03-22 |
| JP2022519239A5 true JP2022519239A5 (enExample) | 2023-02-06 |
| JP7637626B2 JP7637626B2 (ja) | 2025-02-28 |
Family
ID=69780292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544435A Active JP7637626B2 (ja) | 2019-01-30 | 2020-01-28 | アミド二置換のピリジンまたはピリダジン化合物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230150979A1 (enExample) |
| EP (1) | EP3917912B1 (enExample) |
| JP (1) | JP7637626B2 (enExample) |
| KR (1) | KR20210121140A (enExample) |
| CN (2) | CN119176796A (enExample) |
| AU (1) | AU2020216914A1 (enExample) |
| BR (1) | BR112021014709A2 (enExample) |
| CA (1) | CA3128014A1 (enExample) |
| EA (1) | EA202192134A1 (enExample) |
| ES (1) | ES3035735T3 (enExample) |
| IL (1) | IL285157B2 (enExample) |
| MX (1) | MX2021008752A (enExample) |
| SG (1) | SG11202108162SA (enExample) |
| WO (1) | WO2020159904A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021202652A1 (en) * | 2020-04-01 | 2021-10-07 | Eternity Bioscience Inc. | Tyrosine kinase 2 inhibitors, preparation methods and medicinal uses thereof |
| US12492184B2 (en) | 2020-12-22 | 2025-12-09 | InventisBio Co., Ltd. | Heteroaryl compounds, preparation methods and uses thereof |
| CA3213816A1 (en) * | 2021-03-16 | 2022-09-22 | Anrui Biomedical Technology (Guangzhou) Co., Ltd. | Amino heteroaryl compounds and compositions |
| WO2022206705A1 (zh) * | 2021-03-30 | 2022-10-06 | 浙江文达医药科技有限公司 | 作为tyk2假激酶结构域抑制剂的杂环化合物及合成方法和用途 |
| JP7740849B2 (ja) * | 2021-05-04 | 2025-09-17 | シャンハイ ゼイ バイオテクノロジー カンパニー リミテッド | 含窒素複素環ピリジン化合物 |
| CA3223641A1 (en) * | 2021-06-22 | 2022-12-29 | Wenyuan Qian | Sulfoximine compound and use thereof |
| EP4423086A1 (en) | 2021-10-25 | 2024-09-04 | Kymera Therapeutics, Inc. | Tyk2 degraders and uses thereof |
| WO2023213308A1 (zh) * | 2022-05-05 | 2023-11-09 | 苏州隆博泰药业有限公司 | 酰胺取代的杂环化合物及其医药用途 |
| CN120152968A (zh) * | 2022-11-08 | 2025-06-13 | 百时美施贵宝公司 | 取代的杂环化合物 |
| CN120239699A (zh) * | 2022-12-22 | 2025-07-01 | 祐森健恒生物医药（上海）有限公司 | 一种吡啶多取代化合物的盐型、晶型及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3495358T (lt) * | 2012-11-08 | 2022-05-25 | Bristol-Myers Squibb Company | Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai |
| TWI582077B (zh) * | 2013-11-07 | 2017-05-11 | 必治妥美雅史谷比公司 | 作爲ＩＬ－１２、ＩＬ－２３及／或ＩＦＮα反應調節劑之經烷基－醯胺取代之吡啶化合物 |
| US10323036B2 (en) * | 2016-10-14 | 2019-06-18 | Nimbus Lakshmi, Inc. | TYK2 inhibitors and uses thereof |
| JP7631193B2 (ja) * | 2018-10-22 | 2025-02-18 | アルミス インコーポレイテッド | Ｔｙｋ２阻害剤およびその使用 |
| CN115448910B (zh) * | 2019-01-28 | 2024-04-19 | 江苏豪森药业集团有限公司 | 一种哒嗪类衍生物抑制剂、其制备方法和应用 |
-
2020
- 2020-01-28 SG SG11202108162SA patent/SG11202108162SA/en unknown
- 2020-01-28 AU AU2020216914A patent/AU2020216914A1/en not_active Abandoned
- 2020-01-28 MX MX2021008752A patent/MX2021008752A/es unknown
- 2020-01-28 JP JP2021544435A patent/JP7637626B2/ja active Active
- 2020-01-28 WO PCT/US2020/015291 patent/WO2020159904A1/en not_active Ceased
- 2020-01-28 US US17/425,336 patent/US20230150979A1/en not_active Abandoned
- 2020-01-28 KR KR1020217027099A patent/KR20210121140A/ko active Pending
- 2020-01-28 EA EA202192134A patent/EA202192134A1/ru unknown
- 2020-01-28 CN CN202411002531.4A patent/CN119176796A/zh active Pending
- 2020-01-28 BR BR112021014709-8A patent/BR112021014709A2/pt not_active Application Discontinuation
- 2020-01-28 IL IL285157A patent/IL285157B2/en unknown
- 2020-01-28 ES ES20710338T patent/ES3035735T3/es active Active
- 2020-01-28 CN CN202080011693.8A patent/CN113365982A/zh active Pending
- 2020-01-28 EP EP20710338.3A patent/EP3917912B1/en active Active
- 2020-01-28 CA CA3128014A patent/CA3128014A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022519239A5 (enExample) | ||
| JP2022506445A5 (enExample) | ||
| JP2009543836A (ja) | インドール化合物 | |
| AU2007334436A1 (en) | Novel oxadiazole compounds | |
| JP2023542541A5 (enExample) | ||
| JP2017511357A5 (enExample) | ||
| JP2005537255A5 (enExample) | ||
| JP2023533203A5 (enExample) | ||
| JP2021523225A5 (enExample) | ||
| JP2021504314A5 (enExample) | ||
| KR20060117328A (ko) | 면역억제제로서 5-(벤즈-(ｚ)-일리덴-티아졸리딘-4-원유도체 | |
| JP2022525069A5 (enExample) | ||
| JP2024516033A5 (enExample) | ||
| JP2006509842A5 (enExample) | ||
| JP2023528421A5 (enExample) | ||
| JP2019501927A5 (enExample) | ||
| JP2016534984A5 (enExample) | ||
| JP2013515037A5 (enExample) | ||
| JP2008539183A (ja) | オキサゾールおよびチアゾール化合物ならびにｐｇｅ２介在障害の治療におけるそれらの使用 | |
| JP2021512125A5 (enExample) | ||
| WO2010000030A1 (en) | Thiazopyrimidinones and uses thereof | |
| JP2023531495A5 (enExample) | ||
| JP2024535128A5 (enExample) | ||
| RU2005135439A (ru) | Производные индена в качестве фармацевтических средств | |
| JP2021514399A5 (enExample) |